{"id":"https://openalex.org/W1530173448","doi":"https://doi.org/10.1002/cncr.26562","title":"Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first\u2010line platinum\u2010gemcitabine chemotherapy","display_name":"Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first\u2010line platinum\u2010gemcitabine chemotherapy","publication_year":2011,"publication_date":"2011-09-28","ids":{"openalex":"https://openalex.org/W1530173448","doi":"https://doi.org/10.1002/cncr.26562","mag":"1530173448","pmid":"https://pubmed.ncbi.nlm.nih.gov/22031394"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.26562","doi":"https://doi.org/10.1002/cncr.26562","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cncr.26562","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022167252","display_name":"Markus Joerger","orcid":"https://orcid.org/0000-0001-6602-6287","observed_orcids":["https://orcid.org/0000-0001-6602-6287"]},"institutions":[{"id":"https://openalex.org/I2799884508","display_name":"Kantonsspital St. Gallen","ror":"https://ror.org/00gpmb873","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2799884508"]},{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["CH","NL"],"is_corresponding":true,"raw_author_name":"Markus Joerger","raw_affiliation_strings":["Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands. markus.joerger@kssg.ch","Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands","Department of Oncology and Hematology, Cantonal Hospital, St. Gallen, Switzerland","Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands","Fax: (011) 41-71-4942563"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands. markus.joerger@kssg.ch","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Oncology and Hematology, Cantonal Hospital, St. Gallen, Switzerland","institution_ids":["https://openalex.org/I2799884508"]},{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Fax: (011) 41-71-4942563","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049408454","display_name":"Sjaak A. Burgers","orcid":"https://orcid.org/0000-0002-0218-8436","observed_orcids":["https://orcid.org/0000-0002-0218-8436"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Sjaak A. Burgers","raw_affiliation_strings":["Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Paul Baas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Paul Baas","raw_affiliation_strings":["Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016904876","display_name":"Egbert Frederik Smit","orcid":"https://orcid.org/0000-0002-7329-6995","observed_orcids":["https://orcid.org/0000-0002-7329-6995"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Egbert F. Smit","raw_affiliation_strings":["Department of Pulmonary Diseases, Vrije University Medical Center, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pulmonary Diseases, Vrije University Medical Center, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025803452","display_name":"Tjeerd J. Haitjema","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157913","display_name":"Medisch Centrum Alkmaar","ror":"https://ror.org/04vccmr34","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210157913"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Tjeerd J. Haitjema","raw_affiliation_strings":["Department of Pulmonary Diseases, Alkmaar Medical Center, Alkmaar, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pulmonary Diseases, Alkmaar Medical Center, Alkmaar, the Netherlands","institution_ids":["https://openalex.org/I4210157913"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Martin P. L. Bard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin P. L. Bard","raw_affiliation_strings":["Department of Pulmonary Diseases, Kennemer Hospital, Haarlem, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pulmonary Diseases, Kennemer Hospital, Haarlem, the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003864388","display_name":"Valerie D. Doodeman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Valerie D. Doodeman","raw_affiliation_strings":["Department of Molecular Biology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045762300","display_name":"Paul H.M. Smits","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Paul H. M. Smits","raw_affiliation_strings":["Department of Molecular Biology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032847871","display_name":"Andrew D. Vincent","orcid":"https://orcid.org/0000-0002-6428-1070","observed_orcids":["https://orcid.org/0000-0002-6428-1070"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Andrew Vincent","raw_affiliation_strings":["Biometrics Department, The Netherlands Cancer Institute, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biometrics Department, The Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010531755","display_name":"Alwin D. R. Huitema","orcid":"https://orcid.org/0000-0003-1939-4639","observed_orcids":["https://orcid.org/0000-0003-1939-4639"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Alwin D. R. Huitema","raw_affiliation_strings":["Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062227574","display_name":"Jos H. Beijnen","orcid":"https://orcid.org/0000-0003-0118-561X","observed_orcids":["https://orcid.org/0000-0003-0118-561X"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jos H. Beijnen","raw_affiliation_strings":["Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands","Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands","Faculty of Science, Department of Pharmaceutical Sciences, Division of Biomedical Analysis, Department of Drug Toxicology, Utrecht University, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802065108","https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Faculty of Science, Department of Pharmaceutical Sciences, Division of Biomedical Analysis, Department of Drug Toxicology, Utrecht University, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000418012","display_name":"Jan H.M. Schellens","orcid":"https://orcid.org/0000-0001-6832-1976","observed_orcids":["https://orcid.org/0000-0001-6832-1976"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jan H. M. Schellens","raw_affiliation_strings":["Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands","Faculty of Science, Department of Pharmaceutical Sciences, Division of Biomedical Analysis, Department of Drug Toxicology, Utrecht University, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Faculty of Science, Department of Pharmaceutical Sciences, Division of Biomedical Analysis, Department of Drug Toxicology, Utrecht University, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I193662353"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5022167252"],"corresponding_institution_ids":["https://openalex.org/I2799884508","https://openalex.org/I2802065108","https://openalex.org/I2898336195"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":5.1833,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.95469496,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"118","issue":"9","first_page":"2466","last_page":"2475"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.00989999994635582,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/germline-polymorphisms","display_name":"germline polymorphisms","score":0.8999999761581421},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9290000200271606},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9279999732971191},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ercc1","display_name":"ERCC1","score":0.6800000071525574},{"id":"https://openalex.org/keywords/ercc2","display_name":"XPD","score":0.8809999823570251},{"id":"https://openalex.org/keywords/xrcc1","display_name":"XRCC1","score":0.9480000138282776},{"id":"https://openalex.org/keywords/recq1","display_name":"RECQ1","score":0.9509999752044678},{"id":"https://openalex.org/keywords/cda","display_name":"CDA","score":0.9710000157356262},{"id":"https://openalex.org/keywords/gstp1","display_name":"GSTP1","score":0.9919999837875366},{"id":"https://openalex.org/keywords/dna-repair-genes","display_name":"DNA repair genes","score":0.6639999747276306},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7960000038146973},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9679999947547913},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.7919999957084656},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.8220000267028809},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.8849999904632568},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.7279999852180481}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.724275529384613},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6872402429580688},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6135777831077576},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.5211884379386902},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5004491806030273},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4989304542541504},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4703181982040405},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.43423283100128174},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.4294520318508148},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.42499685287475586},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.41654932498931885},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.193496435880661},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.15409806370735168},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13248854875564575},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005854","descriptor_name":"Germ Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1002/cncr.26562","doi":"https://doi.org/10.1002/cncr.26562","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cncr.26562","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:22031394","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22031394","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Clinical Trial"},{"id":"pmh:oai:dare.ubvu.vu.nl:1871/42764","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1871/42764","pdf_url":null,"source":{"id":"https://openalex.org/S4306400546","display_name":"Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"118","raw_type":"Article / Letter to editor"},{"id":"pmh:oai:digital.library.adelaide.edu.au:2440/88091","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2440/88091","pdf_url":null,"source":{"id":"https://openalex.org/S4306401835","display_name":"Adelaide Research & Scholarship (AR&S) (University of Adelaide)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5681781","host_organization_name":"The University of Adelaide","host_organization_lineage":["https://openalex.org/I5681781"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"https://doi.org/10.1002/cncr.26562","raw_type":"Journal article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/11139865-9911-4fa2-b5ce-6b3304e1b07b","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/11139865-9911-4fa2-b5ce-6b3304e1b07b","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Joerger, M, Burgers, S A, Baas, P, Smit, E F, Haitjema, T J, Bard, M P L, Doodeman, V D, Smits, P H M, Vincent, A D, Huitema, A D R, Beijnen, J H & Schellens, J H M 2012, 'Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy A Prospective Clinical Study', Cancer, vol. 118, no. 9, pp. 2466-2475. https://doi.org/10.1002/cncr.26562","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vu2:oai:dare.ubvu.vu.nl:1871/42764","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1871/42764","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer, 118(9), 2466","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/1ab05ad4-4baa-46c0-855a-01fbbe3f5781","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/1ab05ad4-4baa-46c0-855a-01fbbe3f5781","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer, 118(9), 2466 - 2475. John Wiley and Sons Inc.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1972248724","https://openalex.org/W1977179006","https://openalex.org/W1996192566","https://openalex.org/W1997104648","https://openalex.org/W2028998203","https://openalex.org/W2050119069","https://openalex.org/W2050258759","https://openalex.org/W2059584703","https://openalex.org/W2072573995","https://openalex.org/W2079620909","https://openalex.org/W2083189837","https://openalex.org/W2083634237","https://openalex.org/W2096289704","https://openalex.org/W2103088097","https://openalex.org/W2104265571","https://openalex.org/W2109317141","https://openalex.org/W2112089198","https://openalex.org/W2112503651","https://openalex.org/W2113363667","https://openalex.org/W2118170001","https://openalex.org/W2118951956","https://openalex.org/W2139248078","https://openalex.org/W2139819296","https://openalex.org/W2144563146","https://openalex.org/W2148725710","https://openalex.org/W2162460126","https://openalex.org/W2165112400","https://openalex.org/W2166443941","https://openalex.org/W2168655513","https://openalex.org/W2172232429","https://openalex.org/W2179627804","https://openalex.org/W2398473792","https://openalex.org/W2408047432","https://openalex.org/W2418447573"],"related_works":["https://openalex.org/W2590287555","https://openalex.org/W2148725710","https://openalex.org/W2552994841","https://openalex.org/W2965245109","https://openalex.org/W2169416147","https://openalex.org/W1983943864","https://openalex.org/W2388910386","https://openalex.org/W4300467397","https://openalex.org/W2358874408","https://openalex.org/W1600245403"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,75,149],"authors":[2],"assessed":[3],"the":[4,81,98,144,168,192,203,239,271,276,294,315,320],"impact":[5],"of":[6,43,97,143,188,191,297,314],"germline":[7,52,289],"polymorphisms":[8,53,290],"on":[9],"clinical":[10,295],"outcome":[11],"in":[12,57,259,282,312],"patients":[13,30,44,89,283],"with":[14,31,141,232,284],"advanced":[15,285],"nonsmall":[16],"cell":[17],"lung":[18],"cancer":[19],"(NSCLC)":[20],"who":[21,37,237],"received":[22,38,45,49],"platinum-gemcitabine":[23],"(PG)":[24],"chemotherapy.":[25],"METHODS:":[26],"In":[27],"total,":[28],"137":[29],"stage":[32],"IIIB/IV":[33],"NSCLC":[34,286],"were":[35,55,61,185,210,248],"included":[36],"first-line":[39],"PG":[40,298],"chemotherapy":[41,299,311],"(74%":[42],"cisplatin,":[46],"and":[47,72,87,131,167,223],"26%":[48],"carboplatin).":[50],"Twenty-three":[51],"that":[54],"identified":[56],"peripheral":[58],"blood":[59],"samples":[60],"analyzed":[62],"for":[63,252,293,304],"progression-free":[64],"survival":[65,70],"(PFS),":[66],"treatment":[67,94,112],"response,":[68],"overall":[69],"(OS),":[71],"toxicity.":[73],"RESULTS:":[74],"median":[76,82],"PFS":[77,122],"was":[78,84],"5.8":[79],"months,":[80,86],"OS":[83,133],"10.2":[85],"44":[88],"(32%)":[90],"had":[91,109],"a":[92,110],"partial":[93],"response.":[95],"Carriers":[96,190],"excision":[99],"repair":[100],"cross-complementation":[101],"group":[102,152,171],"1":[103,172],"(ERCC1)":[104],"mutant":[105,157,174,193,204,241,263],"thymine":[106],"(T)":[107],"allele":[108,160,177,201,209,318,323],"lower":[111],"response":[113],"rate":[114],"(29%":[115],"vs":[116,218,225,257,261],"52%;":[117],"P":[118,128,137,164,181,266],"=":[119,129,138,165,182,221,228,267],".02),":[120],"shorter":[121,132],"(adjusted":[123,134,161,178],"hazard":[124],"ratio":[125],"[HR],":[126],"1.60;":[127],".04),":[130],"HR,":[135,162,179],"1.54;":[136],".05)":[139],"compared":[140,231],"carriers":[142,313],"wild-type":[145,233,260],"cytosine/cytosine":[146],"(CC)":[147],"genotype.":[148],"xeroderma":[150],"pigmentosum":[151],"A":[153],"member":[154],"10":[155],"(XPD10)":[156],"adenine":[158],"(A)":[159],"0.64;":[163],".04)":[166],"x-ray":[169],"cross-complementing":[170],"(XRCC1)":[173],"guanine":[175],"(G)":[176],"0.51;":[180],".02)":[183],"also":[184,303],"independent":[186],"predictors":[187],"OS.":[189],"adenosine":[194],"triphosphate-dependent":[195],"DNA":[196],"helicase":[197],"Q1":[198],"(RECQ1)":[199],"C":[200,208],"or":[202,319],"cytidine":[205],"deaminase":[206],"(CDA)":[207],"more":[211],"likely":[212],"to":[213,280],"experience":[214],"severe":[215,253],"leukocytopenia":[216],"(26%":[217],"10%":[219],"[P":[220,227],".03]":[222],"28%":[224],"11%":[226],".02],":[229],"respectively)":[230],"genotype":[234,247],"carriers.":[235],"Patients":[236],"carried":[238],"homozygous":[240],"glutathione":[242],"S-transferase":[243],"\u03c0":[244],"1(GSTP1)":[245],"GG":[246],"at":[249],"considerable":[250],"risk":[251],"platinum-associated":[254],"polyneuropathy":[255],"(18%":[256],"3%":[258],"heterozygous":[262],"patients,":[264],"respectively;":[265],".01).":[268],"CONCLUSIONS:":[269],"To":[270],"authors'":[272],"knowledge,":[273],"this":[274],"is":[275],"first":[277],"prospective":[278],"study":[279],"date":[281],"describing":[287],"predictive":[288],"not":[291],"only":[292],"activity":[296],"(ERCC1,":[300],"XPD10)":[301],"but":[302],"its":[305],"toxicity":[306],"(GSTP1,":[307],"RECQ1,":[308],"CDA).":[309],"Nonplatinum-containing":[310],"ERCC1":[316],"T":[317],"XPD10":[321],"G":[322],"should":[324],"be":[325],"studied":[326],"prospectively.":[327]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}